Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in
Pre-market
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverBHST
ConsumerNGMUSD

BioHarvest Sciences Inc. Common Stock

$00123456789.0012345678900123456789+1.4%
52w low $1.42$12.80 52w high
Market data · last updated 1d ago
Market data
Market cap
$33.32M
52w range
$1.42 - $12.80
Beta
1.35
Sector
Consumer
Data quality
83/100
Quality & efficiency
Moat score
35/100
Return on equity
-142.5%
Profit margin
-31.2%
Debt / equity
0.79
Growth & analysts
Revenue growth
+3.8%
Analyst target
$10.50
Target upside
+604.7%
Analysts
4
Run the 10-point checklist before you buy How these numbers are made

About BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company has a strategic collaboration with Tate & Lyle plc for the development of plant-based sweetener molecules. The company is based in Vancouver, Canada.

Valuation

ValueGrowthProfitHealthIncome20QUALITY
Overall Rating
44
Low quality
Low quality

Derived from filed metrics · High confidence (83% of the inputs available)

Moat Score35
Fair value estimate
Not covered by our valuation model yet.

Moat, fair value and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
$33.32M
P/E Ratio
N/A
Dividend Yield
0.00%
Revenue Growth
+3.8%
Profit Margin
-31.2%
ROE
-142.5%
Debt / Equity
0.79
Beta
1.35
Beaten Down

Statistics

Similar Stocks · Consumer

Latest News · BHST